Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review-Reference-Cited by-同舟云学术

Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review

Published:2020-05-26 Issue:5 Volume:33 Page:579-584
ISSN:2191-0251
Container-title:Journal of Pediatric Endocrinology and Metabolism
language:
Short-container-title:

Author:

Cui Han¹,Zhang XiuWei²

Affiliation:

1. Department of Endocrinology, Affiliated Dongguan People’s Hospital, Southern Medical University (Dongguan People’s Hospital), No. 3, South Wandao Road, Xingu Chong, Wanjiang District, Dongguan City, Guangdong Province, China, Phone: +86-13580915733

2. Department of Endocrinology, Affiliated Dongguan People’s Hospital, Southern Medical University (Dongguan People’s Hospital), Dongguan City, Guangdong Province, China

Abstract

AbstractNonalcoholic fatty liver disease (NAFLD) is a metabolic stress-induced liver injury closely correlated with insulin resistance. Currently, the methods for clinical management of NAFLD patients mainly include removing causes, changing lifestyle and dietary structure, drug therapy and weight-loss surgery. This paper summarizes the occurrence and clinical management of NAFLD in patients with obesity, with the aim of formulating scientific clinical interventions for these patients and thus preventing the occurrence of NAFLD.

Publisher

Walter de Gruyter GmbH

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Link

https://www.degruyter.com/document/doi/10.1515/jpem-2019-0595/pdf

Reference80 articles.

1. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis;Lancet (London, England),2010

2. Bariatric surgery for nonalcoholic steatohepatitis: a clinical and cost-effectiveness analysis;Hepatology,2017

3. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss;Hepatology,2010

4. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Hepatology,2018

5. Bariatric surgery in patients with non-alcoholic fatty liver disease – from pathophysiology to clinical effects;World J Hepatol,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory Effects and Molecular Mechanisms of Tea and Its Active Compounds on Nonalcoholic Fatty Liver Disease;Journal of Agricultural and Food Chemistry;2023-02-11

2. Role of pan immune inflammatory value in the evaluation of hepatosteatosis in children and adolescents with obesity;Journal of Pediatric Endocrinology and Metabolism;2022-10-27

3. The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes;Nature Communications;2022-02-25

4. Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-Based Role in Disease Management;Recent Patents on Anti-Cancer Drug Discovery;2021-09-29

5. Identification of hub genes and pathways in nonalcoholic steatohepatitis by integrated bioinformatics analysis;2021-09-11